<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To identify factors that influence the total and negative lymph node counts in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> resection specimens independent of pathologists and surgeons </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: We used multivariate negative binomial regression </plain></SENT>
<SENT sid="2" pm="."><plain>Covariates included age, sex, body mass index, family history of colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp>, year of diagnosis, hospital setting, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> location, resected colorectal length (specimen length), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, circumferential growth, TNM stage, lymphocytic reactions and other pathological features, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> molecular features (microsatellite instability, CpG island methylator phenotype, long interspersed nucleotide element 1 [LINE-1] methylation, and BRAF, KRAS, and PIK3CA mutations) </plain></SENT>
<SENT sid="3" pm="."><plain>SETTING: Two US nationwide prospective cohort studies </plain></SENT>
<SENT sid="4" pm="."><plain>PATIENTS: Patients with rectal and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (N=918) </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN OUTCOME MEASURES: The negative and total node counts (continuous) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Specimen length, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, ascending colon location, T3N0M0 stage, and year of diagnosis were positively associated with the negative node count (<z:hpo ids='HP_0000001'>all</z:hpo> P.002) </plain></SENT>
<SENT sid="7" pm="."><plain>Mutation of KRAS might also be positively associated with the negative node count (P=.03; borderline significance considering multiple hypothesis testing) </plain></SENT>
<SENT sid="8" pm="."><plain>Among node-negative (stages I and II) cases, specimen length, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, and ascending colon location remained significantly associated with the node count (<z:hpo ids='HP_0000001'>all</z:hpo> P.002), and PIK3CA and KRAS mutations might also be positively associated (P=.03 and P=.049, respectively, with borderline significance) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: This molecular pathological epidemiology study shows that specimen length, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> location, TNM stage, and year of diagnosis are operator-independent predictors of the lymph node count </plain></SENT>
<SENT sid="10" pm="."><plain>These crucial variables should be examined in any future evaluation of the adequacy of lymph node harvest and nodal staging when devising individualized treatment plans for patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>